Market Research Future with their unique quality of simplifying the market research study, announces a deep study report on “Injection Pen Market Analysis - Forecast Report Till 2023” Gives industry size, top players and worldwide demand
Market Highlights
The injection pen is a standard delivery device for accurate subcutaneous delivery. A number of factors such as increasing prevalence of chronic diseases, ongoing technological advancements, and improving regulatory framework are fueling the growth of the global injection pen market. According to International Diabetes Federation, in 2016, it was estimated that 420 million adult population were suffering from diabetes which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6146
Moreover, technological advancements in injection pens and increasing product launch by prominent players are likely to drive the market growth during the forecast period. For instance, in 2017, Sanofi launched AllStar pro reusable pen injector across the European market. Furthermore, the increasing application of injection pen in the treatment of various chronic diseases, lifestyle diseases and infertility problems enhance the market growth. Additionally, in November 2017, Merck announced the approval of its new GONAL-f RFF Redi-ject (follitropin alfa injection) prefilled pen by the U.S. FDA.
However, certain issues such as reimbursement issues in the developing nations and presence of alternative drug delivery devices can hamper the growth of the market.
Regional Analysis
The Americas is likely to dominate the global injection pen market owing to the increasing prevalence of cancer and diabetes in the population during the forecast period. In addition, well-established healthcare sector, favorable reimbursement scenario, and growing number of regulatory approvals further drive the growth of the market. According to the WHO, in 2016, 9.6% of total America population were suffering from diabetes. Europe is likely to hold the second position in the global injection pen market. The market growth is attributed to the availability of funds for research, increasing prevalence and government support for research and development. The Asia Pacific is the fastest growing market owing to the huge patient pool with chronic diseases and increasing healthcare expenditure. For instance, according to the WHO (2016), in China, 10% of adults were diagnosed with diabetes. It also stated that type 2 diabetes was found to be the most prevalent type of diabetes in China. The Middle East and Africa injection pen market are expected to grow slowly during the forecast period. Moreover, in this region, Middle East accounts for largest share owing to the increasing presence of prominent market players in the recent years.
Segmentation
The global injection pen market is segmented on the basis of the type, product, therapy, distribution channel, and end users. On the basis of the type, the market is classified into disposable injection pens and reusable injection pens. The global injection pen market on the basis of product is segmented into insulin pens and pen needles. On the basis of the therapy, the market is segmented as diabetes, growth hormone therapy, fertility, osteoporosis, multiple sclerosis, cardiovascular diseases, rheumatoid arthritis, obesity, Crohn’s disease, cancer, and others. Diabetes is further segmented into insulin and GLP-1.On the basis of distribution channel is segmented into hospital pharmacies, retail pharmacies, online medical stores, and diabetes clinics. On the basis of end users, the global injection pen market is segmented into home care and hospitals & clinics.
Global Injection Pen Key Players
Some the prominent players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (U.S.), Sanofi (France), Merck (U.S.), Ypsomed (Switzerland), AstraZeneca (U.K.), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (U.K.), Novartis (Switzerland), Pfizer (U.S.), Haselmeier (Switzerland), Jiangsu Delfu medical device Co. Ltd (China), and Biocon Ltd (India).
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/injection-pen-market-6146
Injection Pen Market AnalysisThe global injection pen market is expected to exhibit a strong 6.5% CAGR over the forecast period from 2018 to 2023, according to the latest market research report from Market Research Future (MRFR).
The global injection pen market is mainly driven by the growing prevalence of chronic diseases requiring frequent injections and the growing awareness about the availability and benefits of injection pens over the conventional vial and syringe system.
The report profiles the major factors affecting the global injection pen market to pinpoint the major drivers and restraints affecting the market and presents a detailed analysis of how the market is likely to grow over the forecast period.The growing prevalence of chronic diseases such as diabetes and osteoporosis is likely to drive the global injection pen market over the forecast period.
Insulin injections are a major application channel for the global injection pen market and are likely to retain their position as such over the forecast period due to the growing prevalence of diabetes and the immense advantages provided by injection pens in terms of managing the progression of diabetes.
Diabetics require a regular administration of insulin injections, which can be cumbersome to handle with the conventional vial and syringe method.
Using an injection pen makes it easier for diabetics to self-manage their disease, making this a key driver for the global injection pen market over the forecast period.The growing product innovation in injection pens is also likely to be a major driver for the global injection pen market over the forecast period, as the technology to make injection pens safer and more effective is high in demand due to the growing popularity of injection pens.
Diabetes Pen Market research report highlights the most important market insights that take business to the highest level of growth and success.
The research, analysis and estimations about the market have been performed with the reliable knowledge in this industry analysis report.Market research analysis is one of the finest options to resolve business challenges quickly by saving lot of time.
The research work, market insights and analysis is carried out thoroughly in this report that puts forth marketplace clearly into the centre of attention.
A transparent research method has been accomplished with the right tools and techniques to make this Diabetes Pen Market research report world-class.
This business report gives an actionable market insight to the clients with which sustainable and profitable business strategies can be created.
Analysis and discussion of important industry trends, market size, sales volume, and market share are also estimated in the report.Get Download Free Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-diabetes-pen-marketThe report contains remarkable market data, present market trends, product consumption, environment, technological innovation, future prospects, upcoming technologies and the technical progress in the related industry.
To win the competition in the global market place, going for this global Diabetes Pen Market research report is necessary.
In this market report, complicated market insights are converted into simpler version with the help of established tools and techniques to provide it to the end users.
Insights covered here enable the buyer of the report to achieve a telescopic view of the competitive landscape and plan the business strategies accordingly to thrive in the market.This Diabetes Pen Market report covers explanation about the detailed market analysis with inputs from industry experts.
Being a third-party report, this report is more unbiased and hence provides a better picture of what is really happening in the market.Get Download Free Sample Copy @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-diabetes-pen-marketA persuasive Diabetes Pen Market research report endows with the key information about the Diabetes Pen industry, including very important facts and figures, expert opinions, and the latest developments across the world.
The expert team, in coordination with project managers, presents the clients on every strategic aspect including product development, key areas of development, application modelling, use of technologies, the acquisition strategies, exploring niche growth opportunities and new markets.This global market report also takes into consideration the drivers and restraints for the Diabetes Pen Market that are derived from SWOT analysis.Segmentation of the Global Diabetes Pen Market –Diabetes Pen Market by Type –Insulin PensInsulin Pen NeedleDiabetes Pen Market by Application –Type 1 DiabetesType 2 DiabetesDiabetes Pen Market by Distribution Channel –Hospital PharmacyRetail PharmacyOnline SalesDiabetes ClinicsTop Key Players of this Global Diabetes Pen Market –AstraZeneca, BD, Eli Lilly and Company, Biocon, Sanofi, Jiangsu Delfu medical device Co., Ltd., Owen Mumford., Wockhardt Limited (India), Smiths Group plc, Nipro Europe Group Companies, Novo Nordisk India Pvt Ltd., InjexUK, Mannkind Corporation, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Copernicus, Ypsomed AG, HTL-STREFA S.A., Merck & Co., Inc., and Bayer AG among other domestic and global playersGet Detailed Toc and Charts & Tables @ https://www.databridgemarketresearch.com/toc/?dbmr=global-diabetes-pen-marketMajor goals of Diabetes Pen Market report can be listed as;Identify the reasons for failure of a product already in the market.Discover the better methods of distributing the products to consumers.Know the types of consumers and their buying motives.Recognize opinions and get suggestion for improvement of a product by consumers.Measure the strength and weakness of the competitors.Know the dimensions of the marketing problems.Estimate the market share of a firm.Calculate the probable sales volume of a firm.Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa)Want Full Report?
Enquire Here - https://www.databridgemarketresearch.com/reports/global-diabetes-pen-marketGlobal Diabetes Pen Market research report offers:Market definition of the global Diabetes Pen market along with the analysis of different influencing factors like drivers, restraints, and opportunities.A comprehensive list of key market players operating in the global Diabetes Pen market.Statistical analysis of some significant economics factsWhich are the key manufacturers in the Diabetes Pen market?About Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
According to a new report by Reports and Data, the Diabetes Injection Pens Market size is expected to register with a CAGR of over 8.5% over the forecast period.
This is mainly due to consistent research activities by academic and scientific organizations and pharmaceutical companies.
Technological interventions have made the market steeply competitive.The report is further attuned to the latest market scenario pertaining to the COVID-19 pandemic and its impact on the key segments of the Diabetes Injection Pens market.
The report analyzes the impact of the pandemic on the supply chain and demands of the market and offers key insights into market growth.
The report also addresses the challenges caused by the pandemic and offers insightful data on how to overcome the barriers.
The research study also includes a current and future assessment of the impact of the COVID-19 pandemic on the overall growth of the Diabetes Injection Pens market.To get a sample PDF copy of the report, visit @ https://www.reportsanddata.com/toc-form/3516The report offers a segmentation analysis of the market to impart a better understanding of the market.
Global Auto-Injectors Market Information, By Product Type Disposable, Reusable and others, By Application Anaphylaxis, Allergies, Multiple Sclerosis, Rheumatoid Arthritis and others, By Suppliers Online Retailers, Pharmacy, Retailers - Forecast Till 2022Auto-Injectors Global Market - Key Players While commenting upon this deep diving study report, presented through more than 100 market data tables and figures, widely spread over 85 pages, the MRFR Research Analyst also mentions that Auto injectors normally are made of glass syringes making them fragile and a probable cause of contamination.
MRFR Analysis identifies following corporations as the key players operating in the global market of auto injectors some of them are: UNILIFE CORPORATION, Scandinavian Health Ltd, Owen Mumford Ltd. (UK), kaleo, Inc., Amedra Pharmaceuticals LLC, Enbrel and others.Segmental AnalysisThe Global Auto-Injector Market has been segmented on the basis of therapy, type, region, and distribution channel.
Based on therapy, the market for autoinjectors has been segmented into multiple sclerosis, diabetes, rheumatoid arthritis, anaphylaxis, and others.
The autoinjectors market includes regions such as Europe, the Middle East, the Americas, Asia Pacific, and Africa.Auto-Injectors Market- OverviewAuto-injectors are spring-loaded syringes, designed to deliver a single dose of a particular life-saving drug.
Most of the injectors are springe-loaded based.Auto-injectors not only allow the automatic injection of a syringe but also have a visual indication that confirms the deliverance of the full dose; hence, these are preferred over the traditional syringes involved in the needle-based drug delivery devices.
Furthermore, the increasing geriatric populace and rapidly changing lifestyle propel the growth of the market.Industry UpdatesNov 2018 The FDA has approved Genentech’s single-dose, prefilled autoinjector ACTPen 162 mg/0.9 mL of tocilizumab (Actemra) for patients with giant cell arteritis (GCA), rheumatoid arthritis (RA), and 2 forms of juvenile arthritis.Detailed Regional AnalysisThe regional analysis of the autoinjectors market finds that the Americas is estimated to control the global autoinjectors market due to a mature healthcare sector, increasing incidence of autoimmune and chronic diseases, and rising healthcare spending.
Global Autoinjectors Market: Information by Product Type (Disposable, Reusable), Design (Customized, Standardized), by Therapeutic Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Others), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others) and Region - Forecast till 2027Market HighlightsThe Global Autoinjectors Market is Estimated to be Valued at USD 79,741 Million by 2024 and is Expected to Register a CAGR of 17.42% During the Forecast Period.The disposable autoinjectors segment is expected to lead the market and register a substantial CAGR to reach USD 53,696.20 Million by the end of 2024.
The increasing demand for testing new drugs and chemicals and vigorous growth in the pharmaceutical and biopharmaceutical sectors are expected to drive the market growth.
Additionally, the disposable autoinjectors segment is also projected to exhibit the highest CAGR of 17.90% from 2019 to 2024.Americas accounted for the largest market share of 40.6% in 2018, and the regional market is projected to register a CAGR of 16.60% during the forecast period.
The Indian market is projected to exhibit the highest growth rate of 18.95% during the forecast period of 2019 to 2024.
The disposable autoinjectors segment held the majority market share in 2018.
It also was the fastest-growing owing to the increasing demand for testing new drugs and chemicals and vigorous growth in the pharmaceutical and biopharmaceutical sectors.Market PlayersMarket Research Future (MRFR) recognizes Amgen Inc. (US), Becton, Dickinson and Company (US), AbbVie Inc. (US), Mylan N.V. (US), Eli Lilly and Company (US), Ypsomed (Switzerland), Owen Mumford Ltd (UK), Consort Medical (UK), SHL Group (Taiwan), Johnson & Johnson Services Inc. (US), Teva Pharmaceutical Industries Ltd (Israel), Antares Pharma (US) as the key players in the Global Autoinjectors Market.Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/6311Regional AnalysisGeographically, the global autoinjectors market has been segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa.
